About this trial
This research is being done to better understand opportunistic infections and cancer in transplant recipients with HIV who receive livers from a donor with HIV compared to livers from donors without HIV.
Eligibility criteria
Qualifiers
Participant meets local criteria for liver or simultaneous liver kidney (SLK) transplant.
Participant or legally authorized representative (in accordance with Johns Hopkins Medicine Institutional Review Board (IRB) and local IRB policy) is able to understand and provide informed consent.
Participant has documented HIV infection by any licensed assay or documented history of detectable HIV-1 RNA.
Participant is ≥ 18 years old.
Disqualifiers
Participant has prior progressive multifocal leukoencephalopathy (PML), cryptosporidiosis of > 1 month duration, or prior primary Central Nervous System (CNS) lymphoma.
Participant is pregnant or breastfeeding.
Past or current medical problems or findings from medical history, physical examination, or laboratory testing that are not listed above, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study.
Trial design
Treatments tested in this trial
- HIV D+/R+
- HIV D-/R+
Treatment groups
Sponsors and collaborators
Johns Hopkins University
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator